# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...
ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $...
The European Patent Office, Japanese Patent Office and IP Australia, the Australian patent office, have recently allowed compos...
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...
ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share. This is a 77.65 percent increase over losses ...